Asthmatx Breathes Easier

Four-year old Asthmatx aims to be the first device company in asthma, a multi-billion dollar drug market. Asthmatx has run its Alair device, which reduces smooth muscle in the lung, through several clinical trials with an eye toward giving a choice to people suffering from the severest forms of the disease.